News
D Molecular Therapeutics (NASDAQ:FDMT) announces a 25% workforce reduction to streamline operations and fund 4D-150's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback